Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Esophageal Neoplasms 2Adenocarcinoma of Lung 1

Interventions

Pemetrexed 3Gefitinib 2Carboplatin 2icotinib 1endostar protein 1apatinib 1Platinum Compounds 1Endostatins 1Drug Therapy 1Cisplatin 1Bevacizumab 1Berberine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Adenocarcinoma of Lung × Platinum Compounds × Clear all
NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Fujian Cancer Hospital

Phase 2 Unknown
50 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡